Targeting of muramyl dipeptide to macrophages by gelatin conjugation to enhance their in vivo antitumor activity
- 31 October 1993
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 27 (1) , 79-88
- https://doi.org/10.1016/0168-3659(93)90059-e
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Suppressive Effect of Recombinant TNF-gelatin Conjugate on Murine Tumour Growth In-vivoJournal of Pharmacy and Pharmacology, 1993
- Macrophage Activation for Antitumour Function by Muramyl Dipeptide-protein ConjugatesJournal of Pharmacy and Pharmacology, 1990
- Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheresJournal of Pharmacy and Pharmacology, 1987
- Phagocytosis of Bioactive MicrospheresJournal of Bioactive and Compatible Polymers, 1986
- Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cellsCancer Immunology, Immunotherapy, 1984
- Tumoricidal activation of murine alveolar macrophages by muramyldipeptide substituted mannosylated serum albuminBiochemical and Biophysical Research Communications, 1984
- Macrophages in cancer metastases and their relevance to metastatic growthCancer and Metastasis Reviews, 1983
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- Discrimination Between Neoplastic and Non-Neoplastic Cells In Vitro by Activated Macrophages12JNCI Journal of the National Cancer Institute, 1974
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974